Anti-cancer drugs (e.g., paclitaxel and rottlerin) have been found to restrain cell proliferation and invasion and promote apoptosis by inhibiting p-AKT (Thr308) and p-AKT (Ser473) in different cancer cells [20,21]. The gene discussed is AKT1; the disease is cancer.